Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Mol Neurobiol. 2014 Dec 11;53(1):595–610. doi: 10.1007/s12035-014-9032-y

Fig. 4.

Fig. 4

Waixenicin A treatment enhances outgrowth and branching of axons and dendrites. a–c Representative images of neurons in different treatment groups on DIV4, DIV6, and DIV8. d Average axonal and e dendritic lengths of DIV4 (control n=56, vehicle n=83, waixenicin A n= 59), DIV6 (control n=50, vehicle n=46, waixenicin A n=49), and DIV8 (control n=50, vehicle n=49, waixenicin A n=32) neurons. f Sholl analysis of axons of DIV8 neurons indicates increased branching and length of branches with waixenicin A treatment (control n=50, vehicle n=49, waixenicin A n=32). g Sholl analysis of dendrites of DIV8 neurons showed increased number of branches only (n=31). Data are shown as mean±SEM. Statistical analysis: one-way ANOVA with Bonferroni post hoc; **p<0.01, ***p<0.001